Envelope glycoproteins of HIV-1 interfere with T-cell-dependent B cell differentiation

Role of CD4-MHC class II interaction in the effector phase of T cell help

N. Chirmule, X. P. Wang, R. Hu, N. Oyaizu, C. Roifman, Rajendra Pahwa, V. S. Kalynaraman, Savita G Pahwa

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

T-cell-dependent B cell differentiation involves two phases: an inductive phase of T cell activation followed by an effector phase, which involves stimulation of B cells by activated T cells. We have previously demonstrated that anti-CD3 mAb and antigen-induced T-cell-dependent B cell functions are inhibited by HIV-1 envelope glycoprotein, gp120, at the inductive phase of T-cell-dependent B cell response. In this study we have investigated whether gpl20 also inhibits the effector phase of interactions involved in T-cell-dependent-B cell differentiation response. For these studies, CD4+ T cells were first activated with antigen or pokeweed mitogen, cultured with soluble HIV gp120 or medium for 2 hr, and washed. Coculture of gp120-treated preactivated T cells with autologous B cells resulted in impairment of IgG secretion, but did not affect IgM secretion significantly. The IgG secretion was restored by the addition of PMA (activator of protein kinase C) or forskolin (activator of adenylate cyclase), but not by the addition of ionomycin (inducer of intracellular calcium) to the T plus B cell cultures. A similar pattern of Ig secretion (IgM, no IgG) was observed with B cells of a patient with bare lymphocyte syndrome, indicating a requirement for MHC class II molecule interaction with T cells. These studies suggest that the effector phase of T-B cell interactions are impaired by gp120, and that the mechanism involves a signal transducing event(s), which is dependent upon cyclic AMP and/or protein kinase C. Furthermore, these latter reactions occur subsequent to T-B cell contact-dependent interactions at the effector phase, which involve MHC class II molecules on B cells and CD4 molecules on T cells.

Original languageEnglish
Pages (from-to)169-182
Number of pages14
JournalCellular Immunology
Volume155
Issue number1
DOIs
StatePublished - Jan 1 1994
Externally publishedYes

Fingerprint

HIV-1
Cell Differentiation
Glycoproteins
B-Lymphocytes
T-Lymphocytes
HIV Envelope Protein gp120
Immunoglobulin G
Protein Kinase C
Immunoglobulin M
CD3 Antigens
Adenylate Kinase
Severe Combined Immunodeficiency
Pokeweed Mitogens
CD4 Antigens
Ionomycin
Colforsin
Coculture Techniques
Adenylyl Cyclases
Cell Communication
Cyclic AMP

ASJC Scopus subject areas

  • Cell Biology
  • Immunology

Cite this

Envelope glycoproteins of HIV-1 interfere with T-cell-dependent B cell differentiation : Role of CD4-MHC class II interaction in the effector phase of T cell help. / Chirmule, N.; Wang, X. P.; Hu, R.; Oyaizu, N.; Roifman, C.; Pahwa, Rajendra; Kalynaraman, V. S.; Pahwa, Savita G.

In: Cellular Immunology, Vol. 155, No. 1, 01.01.1994, p. 169-182.

Research output: Contribution to journalArticle

Chirmule, N. ; Wang, X. P. ; Hu, R. ; Oyaizu, N. ; Roifman, C. ; Pahwa, Rajendra ; Kalynaraman, V. S. ; Pahwa, Savita G. / Envelope glycoproteins of HIV-1 interfere with T-cell-dependent B cell differentiation : Role of CD4-MHC class II interaction in the effector phase of T cell help. In: Cellular Immunology. 1994 ; Vol. 155, No. 1. pp. 169-182.
@article{a251f444d9b74e5ebc4b3e44d9e59c66,
title = "Envelope glycoproteins of HIV-1 interfere with T-cell-dependent B cell differentiation: Role of CD4-MHC class II interaction in the effector phase of T cell help",
abstract = "T-cell-dependent B cell differentiation involves two phases: an inductive phase of T cell activation followed by an effector phase, which involves stimulation of B cells by activated T cells. We have previously demonstrated that anti-CD3 mAb and antigen-induced T-cell-dependent B cell functions are inhibited by HIV-1 envelope glycoprotein, gp120, at the inductive phase of T-cell-dependent B cell response. In this study we have investigated whether gpl20 also inhibits the effector phase of interactions involved in T-cell-dependent-B cell differentiation response. For these studies, CD4+ T cells were first activated with antigen or pokeweed mitogen, cultured with soluble HIV gp120 or medium for 2 hr, and washed. Coculture of gp120-treated preactivated T cells with autologous B cells resulted in impairment of IgG secretion, but did not affect IgM secretion significantly. The IgG secretion was restored by the addition of PMA (activator of protein kinase C) or forskolin (activator of adenylate cyclase), but not by the addition of ionomycin (inducer of intracellular calcium) to the T plus B cell cultures. A similar pattern of Ig secretion (IgM, no IgG) was observed with B cells of a patient with bare lymphocyte syndrome, indicating a requirement for MHC class II molecule interaction with T cells. These studies suggest that the effector phase of T-B cell interactions are impaired by gp120, and that the mechanism involves a signal transducing event(s), which is dependent upon cyclic AMP and/or protein kinase C. Furthermore, these latter reactions occur subsequent to T-B cell contact-dependent interactions at the effector phase, which involve MHC class II molecules on B cells and CD4 molecules on T cells.",
author = "N. Chirmule and Wang, {X. P.} and R. Hu and N. Oyaizu and C. Roifman and Rajendra Pahwa and Kalynaraman, {V. S.} and Pahwa, {Savita G}",
year = "1994",
month = "1",
day = "1",
doi = "10.1006/cimm.1994.1110",
language = "English",
volume = "155",
pages = "169--182",
journal = "Cellular Immunology",
issn = "0008-8749",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Envelope glycoproteins of HIV-1 interfere with T-cell-dependent B cell differentiation

T2 - Role of CD4-MHC class II interaction in the effector phase of T cell help

AU - Chirmule, N.

AU - Wang, X. P.

AU - Hu, R.

AU - Oyaizu, N.

AU - Roifman, C.

AU - Pahwa, Rajendra

AU - Kalynaraman, V. S.

AU - Pahwa, Savita G

PY - 1994/1/1

Y1 - 1994/1/1

N2 - T-cell-dependent B cell differentiation involves two phases: an inductive phase of T cell activation followed by an effector phase, which involves stimulation of B cells by activated T cells. We have previously demonstrated that anti-CD3 mAb and antigen-induced T-cell-dependent B cell functions are inhibited by HIV-1 envelope glycoprotein, gp120, at the inductive phase of T-cell-dependent B cell response. In this study we have investigated whether gpl20 also inhibits the effector phase of interactions involved in T-cell-dependent-B cell differentiation response. For these studies, CD4+ T cells were first activated with antigen or pokeweed mitogen, cultured with soluble HIV gp120 or medium for 2 hr, and washed. Coculture of gp120-treated preactivated T cells with autologous B cells resulted in impairment of IgG secretion, but did not affect IgM secretion significantly. The IgG secretion was restored by the addition of PMA (activator of protein kinase C) or forskolin (activator of adenylate cyclase), but not by the addition of ionomycin (inducer of intracellular calcium) to the T plus B cell cultures. A similar pattern of Ig secretion (IgM, no IgG) was observed with B cells of a patient with bare lymphocyte syndrome, indicating a requirement for MHC class II molecule interaction with T cells. These studies suggest that the effector phase of T-B cell interactions are impaired by gp120, and that the mechanism involves a signal transducing event(s), which is dependent upon cyclic AMP and/or protein kinase C. Furthermore, these latter reactions occur subsequent to T-B cell contact-dependent interactions at the effector phase, which involve MHC class II molecules on B cells and CD4 molecules on T cells.

AB - T-cell-dependent B cell differentiation involves two phases: an inductive phase of T cell activation followed by an effector phase, which involves stimulation of B cells by activated T cells. We have previously demonstrated that anti-CD3 mAb and antigen-induced T-cell-dependent B cell functions are inhibited by HIV-1 envelope glycoprotein, gp120, at the inductive phase of T-cell-dependent B cell response. In this study we have investigated whether gpl20 also inhibits the effector phase of interactions involved in T-cell-dependent-B cell differentiation response. For these studies, CD4+ T cells were first activated with antigen or pokeweed mitogen, cultured with soluble HIV gp120 or medium for 2 hr, and washed. Coculture of gp120-treated preactivated T cells with autologous B cells resulted in impairment of IgG secretion, but did not affect IgM secretion significantly. The IgG secretion was restored by the addition of PMA (activator of protein kinase C) or forskolin (activator of adenylate cyclase), but not by the addition of ionomycin (inducer of intracellular calcium) to the T plus B cell cultures. A similar pattern of Ig secretion (IgM, no IgG) was observed with B cells of a patient with bare lymphocyte syndrome, indicating a requirement for MHC class II molecule interaction with T cells. These studies suggest that the effector phase of T-B cell interactions are impaired by gp120, and that the mechanism involves a signal transducing event(s), which is dependent upon cyclic AMP and/or protein kinase C. Furthermore, these latter reactions occur subsequent to T-B cell contact-dependent interactions at the effector phase, which involve MHC class II molecules on B cells and CD4 molecules on T cells.

UR - http://www.scopus.com/inward/record.url?scp=0028207666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028207666&partnerID=8YFLogxK

U2 - 10.1006/cimm.1994.1110

DO - 10.1006/cimm.1994.1110

M3 - Article

VL - 155

SP - 169

EP - 182

JO - Cellular Immunology

JF - Cellular Immunology

SN - 0008-8749

IS - 1

ER -